Speaker

Ammar Al-Chalabi is a Consultant Neurologist at King’s College Hospital, NIHR Senior Investigator and Professor of Neurology and Complex Disease Genetics at the Maurice Wohl Clinical Neuroscience Institute at King’s College London, and Director of the King’s Motor Neuron Disease Care and Research Centre. His research focuses on amyotrophic lateral sclerosis, also known as ALS, MND or motor neuron disease. Al-Chalabi research team works on finding the causes of ALS, potential treatments, and what might influence the way the disease manifests and progresses, particularly where this involves genes, environmental exposures, or lifestyle, or involves changes in thinking and coping. He runs a large clinical research programme along with clinical trials. He leads or co-leads multinational consortia, such as the Neurodegenerative Disease Joint programme STRENGTH, BRAIN-MEND, and Project MinE initiatives. He is the recipient of several international awards including the Sheila Essey Award for ALS Research from the American Academy of Neurology and ALS Association, the Forbes Norris Award from the International Alliance of ALS/MND Associations, and the AMG Healey Innovation Prize for ALS Research. He has held honorary positions abroad at Massachusetts General Hospital, Harvard University and Cold Spring Harbor Laboratory.

« Go Back